Nina Russell
Directeur/Membre du Conseil chez Global HIV Vaccine Enterprise
Profil
Nina Russell has held director positions at the Global HIV Vaccine Enterprise and The Barth Syndrome Foundation, Inc.
Postes actifs de Nina Russell
| Sociétés | Poste | Début |
|---|---|---|
Global HIV Vaccine Enterprise
 Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
The Barth Syndrome Foundation, Inc.
 The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Commercial Services |
The Barth Syndrome Foundation, Inc.
The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome. | Commercial Services |